Navigation Links
Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG
Date:1/12/2009

BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced the signing of an option, collaboration and license agreement with Bayer Schering Pharma AG, Germany, under which Bayer Schering Pharma has the exclusive option to obtain a license to one of Micromet's preclinical BiTE antibodies against an undisclosed oncology target.

Under the terms of the agreement, Bayer Schering Pharma will pay Micromet a Euro 4.5 million fee (approx. US$ 6 million) to secure a one year option on a specific BiTE antibody. Bayer Schering Pharma may exercise this option prior to January 5, 2010 through the additional payment of an option exercise fee. The exercise of the option would trigger a formal collaboration between Micromet and Bayer Schering Pharma on the development of the BiTE antibody through the completion of phase 1 clinical trials, at which point Bayer Schering Pharma would assume full control of the further development and commercialization of the BiTE antibody. Micromet would be eligible for an option exercise fee and milestone payments of up to Euro 290 million (approx. US$ 390 million) in total and up to double digit royalties based on tiered net sales of the product. In addition, Micromet would be reimbursed for its R&D expenses incurred in connection with the development of the BiTE antibody in the collaboration with Bayer Schering Pharma.

"We are very pleased with Bayer Schering Pharma's interest in this preclinical BiTE antibody program and their financial commitment to secure exclusive access for the next 12 months. This deal represents further validation of our BiTE antibody technology by a major oncology company," said Christian Itin, Micromet's
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2009)...An international team of researchers has modified ...extremely efficient light antennae of bacteria. Th... these light antennae. This is the first step to c... leaf. The researchers will be publishing an artic...Edition of the PNAS journal in the week starting...
(Date:6/30/2009)..., LONDON, June 30 VEGA P... announced it has chosen Chattanooga, TN based con...ist the Company in building a biomass production f...ed its intention to build a biomass plant in Georg...aterials in the State,s Bioenergy Corridor. Georg...
(Date:6/30/2009)..., Second Quarter 2009 Earnings Conference Call Tue..., FRAZER, Pa., June 30 ... regular quarterly earnings conference call coveri...n Tuesday, August 4, 2009. , , August 4, 200...lts will be distributed by PRNewswire, 4:50 p....
(Date:6/30/2009)..., - The 2,292-ton Ocean Lala sailed from the Taich...passengers and 23 crew members - , , CITY OF ...e-FirstCall/ -- EFT BioTech Holdings, Inc. (Pink S...bsidiary, Excalibur International Marine Corporati...s the Taiwan Strait on June 28, 2009. The voyage ...
Breaking Biology Technology:First step to converting solar energy using 'artificial leaf' 2Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia 2EFT BioTech Holdings, Inc.'s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 2EFT BioTech Holdings, Inc.'s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 3
...dicine tools for use by self-insured companies pla... Web to prod patients to lower their health risks....at allow employers to predict health risk exposure...avoidance. In September the company launched eCare...management tool. The eCareConnect suite of online ...
... states staked their territory Tuesday and Wednesd... in hopes of catching the eye of venture and angel...e Conference at Monona Terrace, Madison. , ,Accord...e companies representing not only life sciences b... were so early in the development process that th...
...rkforce for the states burgeoning life sciences in...school awarenessall of which Wisconsin could use m...h Annual Life Sciences and Venture Conference at t...ed forward to the day when the state will be crank..., problem-solving and working in a regulated envir...
...to be the next Silicon Valley? I have lived in bo... to become a Midwest carbon copy of Silicon Valley...ultural differences in business, labor and general...xt century trying to copy their formula and still ... Wisconsin to prosper as a high-tech player is to ...
Other Biology Technology:eCareSolutions to Launch Patient Interaction Product 2eCareSolutions to Launch Patient Interaction Product 3eCareSolutions to Launch Patient Interaction Product 4Investors Pick Favorites at Life Science Conference 2Investors Pick Favorites at Life Science Conference 3Raising a Biotech Workforce - Students, Program Administrators Look to Future 2Raising a Biotech Workforce - Students, Program Administrators Look to Future 3What If We Cut Our Own Path? 2What If We Cut Our Own Path? 3
(Date:7/2/2009)...earchers at Ben-Gurion University of the Negev (BG...elped humans survive may increase the possibility ...e recently the cover story in the journal Genome ...tional Institute for Biotechnology in the Negev (N...f the mitochondria, a part of every cell responsib...
(Date:7/2/2009)...sms and a domain unto themselves, quite apart from...er organisms. Many species live under extreme cond... shared neither with bacteria nor with eukaryotes....methane gas out of carbon dioxide and hydrogen. Th...ves the cofactor known as F0 or F420 which is the ...
(Date:7/2/2009)...roteins that are highly effective at killing bacte... types of antibiotics. , Researchers from the Un...m from the Biotechnology and Biological Sciences R...f proteins known as colicins force their way into ...am, led by Professor Colin Kleanthous, from the Un...
(Date:7/1/2009)...ola and Rift Valley Fever are being targeted as pa...nership involving African researchers and the Lond...uthern African Centre for Infectious Disease Surve...itutions from five African countries and the UK to...etect, identify and monitor infectious diseases af...
Breaking Biology News(10 mins):Ben-Gurion U. researchers reveal connection between cancer and human evolution 2Rampant helper syndrome 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 3Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference June 2 3 2009 47505 1Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference June 2 3 2009 47505 2Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference June 2 3 2009 47505 3Roshan Announces Expansion of Afghanistans First Telemedicine Project to Bamyan Region 47501 1Roshan Announces Expansion of Afghanistans First Telemedicine Project to Bamyan Region 47501 2Roshan Announces Expansion of Afghanistans First Telemedicine Project to Bamyan Region 47501 3Roshan Announces Expansion of Afghanistans First Telemedicine Project to Bamyan Region 47501 4Roshan Announces Expansion of Afghanistans First Telemedicine Project to Bamyan Region 47501 5Roshan Announces Expansion of Afghanistans First Telemedicine Project to Bamyan Region 47501 6Roshan Announces Expansion of Afghanistans First Telemedicine Project to Bamyan Region 47501 7Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 1Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 3Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 5Adult Glioblastoma 3A Best Approaches to a Challenging Diagnosis 47492 1Adult Glioblastoma 3A Best Approaches to a Challenging Diagnosis 47492 2
...n U.S., and probably global, history a fish identi...d -- and in the Hudson River, which flows through ... York City. , The population of shortnose sturgeon...the Atlantic coast of North America, has increased...e the 1970s, report Mark Bain, associate professor...
... indicated that the effects of prion disease could...rs said that their findings support developing ear...rotein in the brains of people with prion disease....ng the efficacy of treatments in a new way: by ana...ice. , The researchers, Giovanna Mallucci and coll...
...s and hardening of the arteries weren,t bad enough...and the Christiana Care Health System in Newark ha...age. , "When you are young, your veins are nice a...a cardiovascular physiologist in UD,s College of H...e found that your veins become more like lead pipe...
...al hearts, can be used to return severely failing ...ing the need for heart transplantation, according ...s Left Ventricular Assist Devices (LVADs), are cur...lure whilst they await transplantation. The new st...ine, shows that using an LVAD combined with certai...
Other Biology News:Endangered shortnose sturgeon saved in Hudson River 2Prion disease treatable if caught early 2Researchers show that veins stiffen as we age 2Researchers show that veins stiffen as we age 3Researchers show that veins stiffen as we age 4Mechanical 'artificial hearts' can remove need for heart transplant by returning heart to normal 2
...39;s NIS-Elements revolutionizes imaging software ...ntelligence to microscopes, cameras, components an...isualization and achiving tools. Its intuitive int...uisition times while providing powerful features s...
GC-RICH PCR System from Roche Applied Science
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine.
...ens ProteinChip System, Series 4000 incorporates t...nical researchers and biologists in biomarker rese...e, offering the fastest route for converting bioma...me platform. The Series 4000 is designed to fit in...
Biology Products: